Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis
- 1 April 1995
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 345 (8953) , 811-816
- https://doi.org/10.1016/s0140-6736(95)92961-4
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolaemiaAtherosclerosis, 1993
- Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemiaAtherosclerosis, 1993
- Regression of coronary atherosclerosis by combined LDL-apheresis and lipid-lowering drug therapy in patients with familial hypercholesterolemia: a multicenter studyAtherosclerosis, 1992
- Response to cholesterol-lowering drugs in familial defective apolipoprotein B-100Atherosclerosis, 1991
- Risk of fatal coronary heart disease in familial hypercholesterolaemia. Scientific Steering Committee on behalf of the Simon Broome Register Group.BMJ, 1991
- Relation of Serum Lipoprotein(a) Concentration and Apolipoprotein(a) Phenotype to Coronary Heart Disease in Patients with Familial HypercholesterolemiaNew England Journal of Medicine, 1990
- The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosisDependence on serum LDL levelsAtherosclerosis, 1986
- Improved survival of patients with homozygous familial hypercholesterolaemia treated with plasma exchange.BMJ, 1985
- Assessment of long-term plasma exchange for familial hypercholesterolaemia.Heart, 1980
- PLASMA EXCHANGE IN THE MANAGEMENT OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIAThe Lancet, 1975